Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives

Details for Australian Patent Application No. 2008206599 (hide)

Owner Repros Therapeutics Inc.

Inventors Podolski, Joseph

Agent Wrays

Pub. Number AU-A-2008206599

PCT Pub. Number WO2008/088935

Priority 60/885,363 17.01.07 US

Filing date 3 January 2008

Wipo publication date 24 July 2008

International Classifications

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

Event Publications

13 August 2009 PCT application entered the National Phase

  PCT publication WO2008/088935 Priority application(s): WO2008/088935

9 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008206643-Composition and method for treating or preventing skeletal muscle fibrosis

2008206593-Lithotripsy basket drill